Highland Private Wealth Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Highland Private Wealth Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,500	Closed	-$49K	–	133
2019 Q1	$49K	Buy	13,500 +3,500	+35%	+$15.2K	0.02%	117
2018 Q4	$61K	Hold	10,000	–	–	0.02%	97
2018 Q3	$58K	Hold	10,000	–	–	0.02%	102
2018 Q2	$43K	Buy	+10,000	New	+$50.4K	0.02%	98

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Highland Private Wealth Management's PETX Position: Q2 2019 in Review

Highland Private Wealth Management sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 13,500 shares — an estimated $49K sold.

Highland Private Wealth Management first reported a position in PETX in Q2 2018 and held it in 4 quarters. The position peaked at $61K in Q4 2018. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

Highland Private Wealth Management reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Highland Private Wealth Management sold 13,500 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $49K.
Highland Private Wealth Management first reported a position in Aratana Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
Highland Private Wealth Management's Aratana Therapeutics, Inc. position peaked at $61K in Q4 2018.
103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Highland Private Wealth Management's 13F filing for Q2 2019, filed 13 Aug 2019.